Literature DB >> 32773469

Antiretrovirals and Risk of COVID-19 Diagnosis and Hospitalization in HIV-Positive Persons.

Julia Del Amo1, Rosa Polo, Santiago Moreno, Asunción Díaz, Esteban Martínez, José Ramón Arribas, Inma Jarrín, Miguel A Hernán.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32773469      PMCID： PMC7541717          DOI： 10.1097/EDE.0000000000001235

Source DB:  PubMed          Journal:  Epidemiology        ISSN： 1044-3983            Impact factor:   4.822


× No keyword cloud information.
  5 in total

1.  Lopinavir-ritonavir in severe COVID-19.

Authors:  Hannah Stower
Journal:  Nat Med       Date:  2020-04       Impact factor: 53.440

2.  Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.

Authors:  Su-Jin Park; Kwang-Min Yu; Young-Il Kim; Se-Mi Kim; Eun-Ha Kim; Seong-Gyu Kim; Eun Ji Kim; Mark Anthony B Casel; Rare Rollon; Seung-Gyu Jang; Min-Hyeok Lee; Jae-Hyung Chang; Min-Suk Song; Hye Won Jeong; Younho Choi; Weiqiang Chen; Woo-Jin Shin; Jae U Jung; Young Ki Choi
Journal:  mBio       Date:  2020-05-22       Impact factor: 7.867

3.  Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors.

Authors:  Belén Alejos; Inés Suárez-García; Otilia Bisbal; José Antonio Iribarren; Víctor Asensi; Miguel Górgolas; Roberto Muga; Santiago Moreno; Inma Jarrín
Journal:  PLoS One       Date:  2019-08-26       Impact factor: 3.240

4.  A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.

Authors:  Bin Cao; Yeming Wang; Danning Wen; Wen Liu; Jingli Wang; Guohui Fan; Lianguo Ruan; Bin Song; Yanping Cai; Ming Wei; Xingwang Li; Jiaan Xia; Nanshan Chen; Jie Xiang; Ting Yu; Tao Bai; Xuelei Xie; Li Zhang; Caihong Li; Ye Yuan; Hua Chen; Huadong Li; Hanping Huang; Shengjing Tu; Fengyun Gong; Ying Liu; Yuan Wei; Chongya Dong; Fei Zhou; Xiaoying Gu; Jiuyang Xu; Zhibo Liu; Yi Zhang; Hui Li; Lianhan Shang; Ke Wang; Kunxia Li; Xia Zhou; Xuan Dong; Zhaohui Qu; Sixia Lu; Xujuan Hu; Shunan Ruan; Shanshan Luo; Jing Wu; Lu Peng; Fang Cheng; Lihong Pan; Jun Zou; Chunmin Jia; Juan Wang; Xia Liu; Shuzhen Wang; Xudong Wu; Qin Ge; Jing He; Haiyan Zhan; Fang Qiu; Li Guo; Chaolin Huang; Thomas Jaki; Frederick G Hayden; Peter W Horby; Dingyu Zhang; Chen Wang
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

5.  Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.

Authors:  Abdo A Elfiky
Journal:  Life Sci       Date:  2020-03-25       Impact factor: 5.037
  5 in total
  7 in total

Review 1.  SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment.

Authors:  Julia Del Amo; Rosa Polo; Santiago Moreno; Inma Jarrín; Miguel A Hernán
Journal:  AIDS       Date:  2022-02-01       Impact factor: 4.177

2.  Tenofovir disoproxil fumarate and coronavirus disease 2019 outcomes in men with HIV.

Authors:  Guilin Li; Lesley S Park; Sara Lodi; Roger W Logan; Emily J Cartwright; Lydia Aoun-Barakat; Juan P Casas; Barbra A Dickerman; Christopher T Rentsch; Amy C Justice; Miguel A Hernán
Journal:  AIDS       Date:  2022-07-15       Impact factor: 4.632

3.  SARS-CoV-2 Infection Is Associated with Uncontrolled HIV Viral Load in Non-Hospitalized HIV-Infected Patients from Gugulethu, South Africa.

Authors:  Humaira Lambarey; Melissa J Blumenthal; Abeen Chetram; Wendy Joyimbana; Lauren Jennings; Marius B Tincho; Wendy A Burgers; Catherine Orrell; Georgia Schäfer
Journal:  Viruses       Date:  2022-06-03       Impact factor: 5.818

4.  Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data.

Authors:  Natalia A Díaz; Rosa de Miguel; Fernando Agüero; Omar Sued; José R Arribas; Juan Ambrosioni
Journal:  Infect Dis Ther       Date:  2021-10-28

5.  Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers.

Authors:  Rosa Polo; Xabier García-Albéniz; Carolina Terán; Miguel Morales; David Rial-Crestelo; M Angeles Garcinuño; Miguel García Del Toro; César Hita; Juan Luis Gómez-Sirvent; Luis Buzón; Alberto Díaz de Santiago; Jose Pérez Arellano; Jesus Sanz; Pablo Bachiller; Elisa Martínez Alfaro; Vicente Díaz-Brito; Mar Masiá; Alicia Hernández-Torres; Jose M Guerra; Jesús Santos; Piedad Arazo; Leopoldo Muñoz; Jose Ramon Arribas; Pablo Martínez de Salazar; Santiago Moreno; Miguel A Hernán; Julia Del Amo
Journal:  Clin Microbiol Infect       Date:  2022-08-05       Impact factor: 13.310

Review 6.  Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection.

Authors:  Isabella Zanella; Daniela Zizioli; Francesco Castelli; Eugenia Quiros-Roldan
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11

7.  Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial.

Authors:  Jean-Jacques Parienti; Thierry Prazuck; Laure Peyro-Saint-Paul; Anna Fournier; Cécile Valentin; Sylvie Brucato; Renaud Verdon; Aymeric Sève; Mathilda Colin; Fabien Lesne; Jérome Guinard; Meriadeg Ar Gouilh; Julia Dina; Astrid Vabret; Laurent Hocqueloux
Journal:  EClinicalMedicine       Date:  2021-06-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.